Thousands are told their
suffering
is unexplained and untreatable.
We're funding the research that's never been done — understanding psychiatric drug withdrawal and comparing those who experience protracted withdrawal to those who don't, starting at the cellular level.
"Understanding withdrawal. Restoring health."
THE SCALE OF THE PROBLEM
What the data tells us - and what it doesn't
Psychiatric medication use is widespread. Research into what happens to the body after cessation is lagging far behind research into starting them.
Adults
16.5 % of U.S. adults
In 2020, 20.3% of adults had received any mental health treatment in the past 12 months, including 16.5% who had taken medication for their mental health, and 10.1% who received counseling or therapy from a mental health professionalÂ
Youth
8.3% of the youth
Psychotropic medication use among youth increased from 5.3% in 2001-2004 to 8.3% in 2017–March 2020  (adjusted time trend: 0.7 percentage points over 4 years; 95% CI: 0.3-1.1), with statistical increases observed among children and young adults, driven mainly by stimulants
0
Comparitive studies
The same drug, the same taper, the same dose — and wildly different outcomes. Without head-to-head comparison studies, clinicians have insufficient ways to predict, prevent, or treat protracted symptoms.
Become a founding donor
Withdrawal Incidence
up to 56%Â
Systematic reviews estimate that up to 56% of people who attempt to stop antidepressants experience withdrawal effects; nearly half of those describe the effects as severe.
1
Dedicated organization
We are the first organization dedicated to facilitating research into the biological mechanism of nervous system destabilization, starting from the mitochondria.
Protracted Withdrawal
months to years
For a subset of people, withdrawal effects don't resolve in days or weeks as guidelines suggest — they persist for months or years, a phenomenon clinical guidance still doesn't fully account for.